rethinkPeptides Search
Menu
Study breakdown

Scorpion Venom: A Natural Source of Therapeutic Peptides for Cancer, Pain, and Infections

ReviewPreliminary evidence
The takeaway

Comprehensive review of scorpion venom-derived peptides reveals diverse therapeutic potential including anticancer, antimicrobial, anti-inflammatory, and analgesic applications.

Millions of years optimized

Scorpion venom peptides evolved to target ion channels and membranes, now being developed as drugs for cancer, pain, and infections

What the researchers found

Scorpion venom contains diverse bioactive peptides with anticancer, antimicrobial, analgesic, and anti-inflammatory properties, with several candidates advancing toward clinical development.

Why it matters

Nature has spent millions of years optimizing venom peptides to affect biological targets. Harnessing these natural molecules could provide entirely new classes of drugs for cancer, infections, and pain — conditions where current treatments fall short.

The numbers in context

No specific clinical trial numbers — this is a review of the breadth of therapeutic applications across the field.

How the study worked

Comprehensive review of scorpion venom peptide characterization, mechanisms of action, and therapeutic applications across multiple disease areas.

Who was studied

N/A — review of preclinical venom peptide research

What this study cannot tell us

Most scorpion venom peptides are in early development. Venom peptides may have toxicity issues. Manufacturing synthetic versions at scale is challenging. Moving from venom characterization to clinical drugs takes years.

How to read the evidence

Moderate evidence: comprehensive review of a well-characterized natural product source with multiple preclinical candidates.

When this study was published

Published in 2025. Captures the latest advances in venom peptide drug development.

The bigger picture

Venom-derived drugs have a proven track record — captopril (from snake venom) and ziconotide (from cone snails) are approved drugs. Scorpion venoms represent the next frontier, with peptide libraries that pharmaceutical companies are now mining for drug candidates using modern screening technologies.

Questions still open

  • Which scorpion venom peptides are closest to clinical trials?
  • Can venom peptides be modified to reduce toxicity while maintaining therapeutic activity?
  • Could synthetic biology produce scorpion venom peptides more efficiently than harvesting from scorpions?

Common questions

Are drugs really made from scorpion venom?
Yes — scorpion venoms contain hundreds of peptides that target specific biological processes. Drugs from other venoms are already approved (like captopril from snake venom). Several scorpion peptides are being developed for cancer, pain, and infections.
How can something toxic become medicine?
Venom peptides are extremely precise in what they target — that precision is exactly what makes good drugs. By isolating specific peptides, modifying them for safety, and using them at controlled doses, researchers can harness the therapeutic effects while avoiding toxicity.

Read the original research

Scorpion venom as a natural peptide source for innovative therapeutic solutions: A comprehensive review of its potential in emerging medical frontiers.

Toxicon : official journal of the International Society on Toxinology, 268, 108603

Citation

Abdallnasser Amen, Radwa; Atef Essmat, Rawan; Farid, Alyaa; Abdel-Rahman, Mohamed A; El-Sherif, Ahmed A; Zhang, Yonghong. (2025). Scorpion venom as a natural peptide source for innovative therapeutic solutions: A comprehensive review of its potential in emerging medical frontiers.. Toxicon : official journal of the International Society on Toxinology, 268, 108603. https://doi.org/10.1016/j.toxicon.2025.108603